Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease

Arastoo M, Lofthouse R, Penny LK, Harrington CR, Porter A, Wischik CM, Palliyil S.

Int J Mol Sci. 2020 Nov 17;21(22):8673. doi: 10.3390/ijms21228673.

[Analysis of cerebrospinal fluid in the diagnosis of cognitive impairment and dementia]

Frederiksen KS, Hasselbalch S, Waldemar G.

Ugeskr Laeger. 2020 Nov 2;182(45):V05200352.

Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia

Funnell C, Feldman HH, Mackenzie IRA, DeMarco ML.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):357-359. doi: 10.1097/WAD.0000000000000372.

A Multilevel View of the Development of Alzheimer's Disease

Avila J, Perry G.

Neuroscience. 2021 Mar 1;457:283-293. doi: 10.1016/j.neuroscience.2020.11.015. Epub 2020 Nov 24.

Comprehensive Review on Alzheimer's Disease: Causes and Treatment

Breijyeh Z, Karaman R.

Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.

Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis

Chaudhry A, Rizig M.

J Neurol Sci. 2021 Feb 15;421:117270. doi: 10.1016/j.jns.2020.117270. Epub 2020 Dec 15.

Inflammatory Biomarkers in AD: Implications for Diagnosis

Kim J, Kim YK.

Curr Alzheimer Res. 2020;17(11):962-971. doi: 10.2174/1567205017666201223152612.

Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer's disease biofluid-based biomarker studies

Babulal GM.

J Neurol Sci. 2021 Feb 15;421:117269. doi: 10.1016/j.jns.2020.117269. Epub 2020 Dec 14.

European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment

Frederiksen KS, Nielsen TR, Winblad B, Schmidt R, Kramberger MG, Jones RW, Hort J, Grimmer T, Georges J, Frölich L, Engelborghs S, Dubois B, Waldemar G.

Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.

Blood biomarkers in Alzheimer's disease

Altuna-Azkargorta M, Mendioroz-Iriarte M.

Neurologia (Engl Ed). 2021 Nov-Dec;36(9):704-710. doi: 10.1016/j.nrleng.2018.03.006. Epub 2020 Feb 19.

Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial

Vila-Castelar C, Ly JJ, Kaplan L, Van Dyk K, Berger JT, Macina LO, Stewart JL, Foldi NS.

Arch Clin Neuropsychol. 2019 May 1;34(3):277-289. doi: 10.1093/arclin/acy032.

99mTc-labeled Small Molecules for Diagnosis of Alzheimer's Disease: Past, Recent and Future Perspectives

Molavipordanjani S, Emami S, Hosseinimehr SJ.

Curr Med Chem. 2019;26(12):2166-2189. doi: 10.2174/0929867325666180410104023.

Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer's Disease

Yang J, Yang J, Li Y, Xu Y, Ran C.

Mol Imaging Biol. 2019 Feb;21(1):35-43. doi: 10.1007/s11307-018-1213-z.

[Collation of word retrieval disorders in patients with Alzheimer's dementia]

Camerer-Waldecker C, Supprian T.

Nervenarzt. 2019 Apr;90(4):399-407. doi: 10.1007/s00115-018-0572-7.

Effects of Acupuncture on Alzheimer's Disease: Evidence from Neuroimaging Studies

Yu CC, Ma CY, Wang H, Kong LH, Zhao Y, Shen F, Wu M.

Chin J Integr Med. 2019 Aug;25(8):631-640. doi: 10.1007/s11655-018-2993-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias